Seminars in Nuclear Medicine
Volume 31, Issue 2 , Pages 102-123 , April 2001

Radiolabeled peptides in the detection of deep venous thrombosis

    MD, FRCPC
  • Raymond Taillefer

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Raymond Taillefer, MD, FRCPC, Department of Nuclear Medicine, Hotel-Dieu de Montreal, 3840 rue St-Urbain, Montreal, Canada H2W 1T8.

References 

  1. Freiman DG. The structure of thrombi. In: Colman RW, Hirsh J, Marder VJ, et al. editor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott; 1987;p. 1123–1135
  2. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation. 1996;93:2212–2245
  3. Moser KM. Venous thromboembolism. Am Rev Respir Dis. 1990;141:235–249
  4. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;17:259–270
  5. Anderson FA, Wheeler HB, Goldberg RT, et al. A population-based perspective of the hospital incidence and case facility rates of deep vein thrombosis and pulmonary embolism. Ann Intern Med. 1991;151:933–938
  6. Kaunitz AM, Hughes JM, Grimes DA, et al. Causes of maternal mortality in the United States. Obstet Gynecol. 1985;65:605–612
  7. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983;98:891–899
  8. Strandness DE, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA. 1983;250:1289–1292
  9. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Inter Med. 1996;125:1–7
  10. Salzman EW, Hirsh J. The epidemiology, pathogenesis, and natural history of venous thrombosis. In: Coleman RW, Hirsh J, Marder VJ, et al. editor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. ed 3. Philadelphia, PA: Lippincott; 1993;p. 1275–1296
  11. Raskob GE, Durica SS, George JN. Complications of heparin. In: Hull RD, Raskob GE, Pineo GF editor. Venous Thromboembolism: An Evidence-Based Atlas. New York, NY, Armonk: Futura; 1996;p. 223–239
  12. Hirsh J, Raschke R, Warkentin TE, et al. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108(suppl 4):258S–275S
  13. Wells RD, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345:1326–1330
  14. Stamatakis JD, Kakkar VV, Lawrence D, et al. The origin of thrombi in the deep veins of the lower limb: A venography study. Br J Radiol. 1978;65:449–451
  15. Lensing AWA, Prandoni P. Distribution of venous thrombi in symptomatic patients. Thromb Haemost. 1991;65:1730–1736
  16. Hull RD, Hirsh J, Carter C, et al. Diagnostic efficacy of impedance plethysmography for clinically suspected DVT: A randomized trial. Ann Intern Med. 1985;102:21–26
  17. Lensing AWA, Prandoni P, Brandjes D, et al. Detection of deep venous thrombosis by real-time B-mode ultrasonography. N Eng J Med. 1989;320:342–346
  18. Lensing AWA, Hirsh J, Buller HR. Diagnosis of venous thrombosis. In: Coleman RW, Hirsh J, Marder VJ, et al. editor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott; 1987;p. 1297–1302
  19. Anand SS, Wells PS, Hunt D, et al. Does this patient have deep vein thrombosis?. JAMA. 1998;279:1094–1099
  20. Hull RD, Carter CJ, Jay RM, et al. The diagnosis of acute recurrent deep vein thrombosis: A diagnostic challenge. Circulation. 1983;67:901–906
  21. Cronan JJ. Venous thromboembolic disease: The role of ultrasound. Radiology. 1993;186:619–630
  22. Rose SC, Zwiebel WJ, Nelson BD, et al. Symptomatic lower extremity deep venous thrombosis: Accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology. 1990;175:639–644
  23. Lensing AWA, Doris I, McGrath FP, et al. A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. Arch Intern Med. 1997;157:765–768
  24. Davidson BL, Elliott CG, Lensing AWA. Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. Ann Intern Med. 1992;117:735–738
  25. Cronan JJ, Leen V. Recurrent deep venous thrombosis: Limitations of ultrasound. Radiology. 1989;170:739–742
  26. Screaton NJ, Gillard JH, Berman LH, et al. Duplicated superficial femoral veins: A source of error in the sonographic investigation of deep vein thrombosis. Radiology. 1998;206:397–401
  27. Taillefer R. Detection of deep venous thrombosis with 99mTc-labeled peptides. In: Freeman L editors. Nuclear Medicine Annual 2000. Philadelphia, PA: Lippincott Williams & Wilkins; 2000;p. 111–142
  28. Nicolaides AN, Kakkar VV, Field ES, et al. The origin of deep vein thrombosis: A venographic study. Br J Radiol. 1971;44:653–663
  29. Coleman RW, Cook JJ, Niewiarowski S. Mechanisms of platelet aggregation. In: Coleman RW, Hirsh J, Marder VJ, et al. editor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. ed 3. Philadelphia, PA: Lippincott; 1994;p. 508–523
  30. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979;254:357–363
  31. Freiman DG. The structure of thrombi. In: Coleman RW, Hirsh J, Marder VJ, et al. editor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott; 1987;p. 1123–1135
  32. Ezekowitz MD, Pope CF, Sostman HD, et al. 111In platelet scintigraphy in the diagnosis of acute venous thrombosis. Circulation. 1986;73:668–674
  33. Clark-Pearson DL, Coleman RE, Siegal R, et al. 111In platelet imaging for the detection of deep venous thrombosis and pulmonary embolism in patients without symptoms after surgery. Surgery. 1985;98:98–104
  34. Thakur ML, Welch MJ, Joyst JH, et al. 111In labeled platelets: Studies in preparation and evaluation of in vitro and in vivo functions. Thromb Res. 1976;9:345–357
  35. Seabold JE, Conrad GR, Kimball DA, et al. Pitfalls in establishing the diagnosis of deep venous thrombosis by 111In platelet scintigraphy. J Nucl Med. 1988;29:1169–1180
  36. Lister-James J, Knight LC, Maurer AH, et al. Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide. J Nucl Med. 1996;37:775–781
  37. Taillefer R, Thérasse E, Turpin S, et al. Comparison of early and delayed imaging with 99mTc-apcitide (99mTc-P280) in detection of acute deep venous thrombosis: Correlation with contrast venogram. J Nucl Med. 2001;40:2028–2035
  38. Muto P, Lastoria S, Varella P, et al. Detection of deep venous thrombosis with 99mTc-labeled synthetic peptide P280. J Nucl Med. 1995;36:1384–1391
  39. (abstr) Weiland FL, Carretta RF, Holder LE, et al. Tc-99m P280 detection of deep venous thrombosis (DVT) in patients with a prior history of DVT. J Nucl Med. 1997;38:98
  40. (abstr) Taillefer R, Abdel-Nabi HH, Buxton-Thomas M, et al. Multicenter clinical trial comparing Tc-99m P280 to contrast venography for detection and localization of acute deep venous thrombosis. J Nucl Med. 1997;38:98
  41. (abstr) Weiland FL, Carretta RF, Holder FE, et al. Safety and efficacy of Tc-99m P280 for the detection and localization of acute deep venous thrombosis. J Nucl Med. 1997;38:98
  42. Taillefer R, Edell S, Innes G, et al. Acute thromboscintigraphy with 99mTc-apcitide: Results of the Phase 3 multicenter clinical trial comparing 99mTc-apcitide scintigraphy with contrast venography for imaging acute deep venous thrombosis. J Nucl Med. 2000;41:1214–1223
  43. McLaughlin MSF, Thomson JG, Taylor DW, et al. Observer variation in the interpretation of lower limb venograms. AJR Am J Roentgenol. 1979;132:227–229
  44. Hull R, Hirsh J, Sackett DL, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation. 1981;64:6220625
  45. 11P Easton EJ. Acutect and pulmonary embolism. (abstr) J Nucl Med. 1999;40:
  46. 152P Seabold JE, Salisbury SM, Edell SL, et al. Does heparin therapy affect the results of 99mTc-DMP 444 scintigraphy for detection of acute deep vein thrombosis (DVT)?. (abstr) J Nucl Med. 1999;40:
  47. 12P Seabold JE, Tulchinsky M, Edell SL, et al. 99mTc DMP-444 peptide scintigraphy for detection of acute deep vein thrombosis: A multicenter clinical trial. (abstr) J Nucl Med. 2000;41:
  48. 12P Borg BD, Tulchinsky M, Pellegrini VD. Detection of deep venous thrombosis by thromboscintigraphy with DMP-444 after total knee arthroplasty. (abstr) J Nucl Med. 2000;41:
  49. Ezov N, Nimrod B, Parizada B, et al. Recombinant polypeptides derived from the fibrin binding domain of fibronectin are potential agents for the imaging of blood clots. Thromb Haemost. 1997;77:796–803
  50. Rosenthall L, Leclerc J. A new thrombus imaging agent: Human recombinant fibrin binding domain labeled with 111In. Clin Nucl Med. 1995;20:398–402
  51. 12P Taillefer R, Barnes D, Hill J, et al. 99mTc-FBD (fibrin binding domain of fibronectin) scintigraphy in patients with acute deep vein thrombosis: Results of the phase II multicenter trial. (abstr) J Nucl Med. 2000;41:
  52. Wells PS, Anderson DA, Bormanis J, et al. Value of assessment of pre-test probability of deep-vein thrombosis in clinical management. Lancet. 1997;350:1795–1798
  53. 122P Knight LC, Baidoo KE, Romano JE, et al. 99mTc-labeled bitistatin for imaging pulmonary emboli and deep venous thrombi. (abstr) J Nucl Med. 1999;40:
  54. 121P Pallela VR, Thakur ML, Consigny PM, et al. Imaging vascular thrombosis with 99mTc-labeled fibrin binding peptide. (abstr) J Nucl med. 1999;40:
  55. 198P Cyr JE, Nelson CA, Pearson DA, et al. 99mTc-radiolabeling and biological evaluation of a new GP IIb/IIIa receptor binding agent. P424. (abstr) J Nucl Med. 1999;40:

PII: S0001-2998(01)80039-8

doi: 10.1053/snuc.2001.21268

Seminars in Nuclear Medicine
Volume 31, Issue 2 , Pages 102-123 , April 2001

Article Tools